Le Lézard
Classified in: Science and technology, Business
Subject: CON

Carrieverse and Bybit enter into a strategic partnership


SEOUL, South Korea, Dec. 7, 2023 /PRNewswire/ -- Carrieverse Co., Ltd., developer of the Web3 gaming platform 'Cling' and the issuer of the virtual asset $CVTX, has entered into a strategic partnership with the global virtual asset exchange Bybit. Through the partnership, Carrieverse will become an ecosystem partner of Bybit, and through Bybit's full support and cooperation, it will carry out comprehensive marketing and Web3 business activities.

Bybit, established in 2018, is a Singapore-based virtual asset exchange with over 1.5 million users worldwide. According to CoinMarketCap, a virtual asset market broadcasting site, it is a major exchange fluctuating between 2nd and 4th place based on trading volume.

This partnership is the first achievement following last week's entry into the DMCC (Dubai Multi Commodities Centre) by Carrieverse. In June, Bybit and DMCC signed an ecosystem partnership and agreed to sponsor 15 new Web3 and crypto projects. Bybit has also committed to provide various advisory and active support for member companies in the DMCC Crypto Centre as its ecosystem partner.

Although many Web3 and crypto projects from around the world have applied to DMCC, the Carrieverse project was selected as a beneficiary after a stringent review process. DMCC Crypto Centre commented that Carrieverse's completeness and marketing strategies received good scores during the review process, highly evaluating Carrieverse. With this active support from DMCC, Carrieverse was able to establish a high-level partnership with Bybit. Carrieverse plans to expand the global Web3 ecosystem through continuous major partnerships, unfolding a triangular strategy linking Carrieverse, Bybit, and DMCC.

Both parties plan to carry out close marketing collaborations through this partnership. In particular, Leila Mcharek, Vice President of Global Business and Strategic Partnerships at Bybit, emphasized that Bybit will focus on creating a suitable environment for Carrieverse to become a spotlight project of Bybit, stating, "Our collaboration with Carrieverse will elevate our blockchain platform to a new dimension. We will also provide thorough support for Carrieverse to expand its global ecosystem." 

Details of the partnership can be found through Carrieverse' official community and Bybit's website.

Carrieverse Official Community
https://discord.gg/carrieverse

Bybit Landing Page
https://announcements.bybit.com/en/article/carrieverse-blt69d4de3a79649219

Photo - https://mma.prnewswire.com/media/2295416/image_5006615_27206125.jpg 


These press releases may also interest you

at 18:05
Reality TV Star, Mollie Pearce, Backs Campaign to Tackle Inequalities in Condition That Impacts Millions of People Globally
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 13:27
Industrial Automation Market In Life Sciences Industry size is set to grow by USD 5.06 bn from 2024-2028, growing global demand for healthcare services to boost the market growth, Technavio
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 10:15
Ibbaka Revenue Retention Maturity Model Helps B2B SaaS Companies Uncover Hidden Opportunities Within Customer Revenue Growth
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

at 08:35
Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals' LIVMARLI Data Showcased at ESPGHAN Annual Meeting
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

at 06:47
After Launching Massive Camp Giveaway for NYC Families Affected by "Summer Rising" Crisis, Brains & Motion Education (BAM!) Extends Initiative to SF Bay Area Families
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...

More news about Science and technology...


News published on and distributed by: